Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells.

Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells.
复制标题

DOI:
10.1016/j.ebiom.2018.08.014
复制
发表时间:
2018-09
期刊:
影响因子:
11.1
通讯作者:
Taniguchi H
Taniguchi H
中科院分区:
医学1区
文献类型:
--
作者:
Nie YZ;Zheng YW;Miyakawa K;Murata S;Zhang RR;Sekine K;Ueno Y;Takebe T;Wakita T;Ryo A;Taniguchi H

文献摘要

参考文献

被引文献

相似文献

近几十年来,针对B型肝炎病毒(HBV)的治疗方法得到了改善;然而,个体化治疗的发展受到缺乏个体化感染模型的限制。在这项研究中,我们使用人诱导多能干细胞(hiPSC)产生一个功能性肝类器官(LO),继承了供体的遗传背景,并评估其在模拟HBV感染和探索病毒-宿主相互作用中的应用。为了建立功能性hiPSC-LO,我们在三维微孔培养系统中用化学成分确定的培养基培养hiPSC衍生的内胚层、间充质和内皮细胞。基于细胞-细胞相互作用,这些细胞可以自我组织并逐渐分化成功能性类器官,其表现出比hiPSC衍生的肝样细胞(HLC)更强的肝功能。此外,功能性LO表现出比hiPSC-HLC更易受HBV感染,并且可以维持HBV增殖并长时间产生感染性病毒。此外,我们发现病毒感染可导致hiPSC-LO的肝功能障碍,肝脏基因表达下调,诱导释放早期急性肝衰竭标志物,并改变肝脏超微结构。因此,我们的研究表明,hiPSC-LO中的HBV感染可以重现病毒的生命周期和病毒引起的肝功能障碍,这表明hiPSC-LO可能为开发肝炎的个体化治疗提供有希望的个体化感染模型。
Therapies against hepatitis B virus (HBV) have improved in recent decades; however, the development of individualized treatments has been limited by the lack of individualized infection models. In this study, we used human induced pluripotent stem cell (hiPSC) to generate a functional liver organoid (LO) that inherited the genetic background of the donor, and evaluated its application in modeling HBV infection and exploring virus–host interactions. To establish a functional hiPSC-LO, we cultured hiPSC-derived endodermal, mesenchymal, and endothelial cells with a chemically defined medium in a three-dimensional microwell culture system. Based on cell-cell interactions, these cells could organize themselves and gradually differentiate into a functional organoid, which exhibited stronger hepatic functions than hiPSC derived hepatic like cell (HLC). Moreover, the functional LO demonstrated more susceptibility to HBV infection than hiPSC-HLC, and could maintain HBV propagation and produce infectious virus for a prolonged duration. Furthermore, we found that virus infection could cause hepatic dysfunction of hiPSC-LOs, with down-regulation of hepatic gene expression, induced release of early acute liver failure markers, and altered hepatic ultrastructure. Therefore, our study demonstrated that HBV infection in hiPSC-LOs could recapitulate virus life cycle and virus induced hepatic dysfunction, suggesting that hiPSC-LOs may provide a promising individualized infection model for the development of individualized treatment for hepatitis.
DOI: 10.1016/s1473-3099(06)70601-6
发表时间: 2006-10
影响因子: 56.3
作者:
Burgner, David;Jamieson, Sarra E.;Blackwell, Jenefer M.
通讯作者: Blackwell, Jenefer M.
DOI: 10.1073/pnas.84.4.1005
发表时间: 1987-02-01
影响因子: 11.1
作者:
SELLS, MA;CHEN, ML;ACS, G
通讯作者: ACS, G
DOI: 10.1016/j.ccr.2014.01.030
发表时间: 2014-03-17
期刊: CANCER CELL
影响因子: 50.3
作者:
Lau, Chi-Chiu;Sun, Tingting;Wong, Nathalie
通讯作者: Wong, Nathalie
DOI: 10.1016/0016-5085(94)90700-5
发表时间: 1994-03-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
GALLE, PR;HAGELSTEIN, J;ZENTGRAF, H
通讯作者: ZENTGRAF, H
DOI: 10.18632/oncotarget.4808
发表时间: 2015-09-08
期刊: Oncotarget
影响因子: --
作者:
Miyakawa K;Matsunaga S;Watashi K;Sugiyama M;Kimura H;Yamamoto N;Mizokami M;Wakita T;Ryo A
通讯作者: Ryo A